The FDA approved the first cholesterol pill of its kind, offering high-risk patients a new alternative to injectable medications.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

July 17, 2026   |   Listen online   |   Read online FDA Clears Breakthrough Cholesterol Pill That Could Replace Costly Injections The FDA approved the first cholesterol pill of its kind, offering high-risk patients a new alternative to injectable medications.   Tyler Flores What Happened? The Food and Drug Administration has approved a first-of-its-kind cholesterol pill that could expand treatment options for millions of Americans at high risk of heart disease. The medication, developed by Merck and marketed as Lipfendra, is the first oral drug that blocks the PCSK9 protein. That target has previously been treated only with injectable medications. The approval is intended for patients whose LDL, often called "bad" cholesterol, remains too high despite taking statins, the standard drugs used to reduce the risk of heart attacks and strokes. By blocking the PCSK9 protein, the medication helps the body remove more cholesterol from the bloodstream. In clinical trials involving thousands of high-risk patients, those who added Lipfendra to their existing treatment saw LDL cholesterol levels fall by more than 55% after six months. The reduction remained largely intact after one year, while side effects such as dizziness and diarrhea occurred at rates similar to those seen in patients taking a placebo. The FDA approved the drug through its expedited review program for promising new therapies that address significant public health needs. Why It Matters Heart disease is the leading cause of death in the United States for men and women, and high LDL cholesterol is one of its biggest risk factors. While statins are effective for many patients, they do not lower cholesterol enough for everyone, particularly those with existing heart disease or a very high risk of heart attack or stroke. The approval of an oral PCSK9 medication gives doctors another treatment option for patients who need greater cholesterol reduction without relying on injections. The new pill could also improve access to a class of medications that has been underused for years. Injectable PCSK9 drugs have often been limited by high prices, insurance restrictions, and patient reluctance to use regular injections. An oral alternative may be easier for patients to take and for physicians to prescribe, potentially allowing more high-risk Americans to reach recommended cholesterol levels. If that leads to wider use, it could help prevent future heart attacks and strokes while reducing some of the long-term costs associated with cardiovascular disease. How It Affects You For Americans with high cholesterol, especially those who have suffered a heart attack or been diagnosed with heart disease, this approval could give them another option if statins alone are not enough. Instead of adding an injectable medication, eligible patients may be able to take a daily pill that delivers a similar type of cholesterol reduction. That could make treatment easier for people who dislike injections or have trouble keeping up with them. The medication is designed to complement statins rather than replace them, giving doctors another option when cholesterol remains too high despite standard treatment. Access and availability will largely depend on coverage and pricing. Should coverage become widespread, the pill could very well make this type of advanced cholesterol treatment more practical for many high-risk patients by offering an alternative to regular injections while helping reduce the risk of heart attacks and strokes. More breaking news below… Firing of Ukrainian Defense Minister by President Zelenskyy triggers widespread protests in Ukraine. Read more here… President Trump announces the United States will withdraw all military personnel from Iraq by September 30th. Read more here… The Trump administration is tightening student and journalist visa rules, reshaping legal immigration with new limits, deadlines, and oversight requirements. Read more here… Republican lawmakers are urging Canada to strengthen wildfire prevention as smoke continues to degrade air quality across parts of the United States. Read more here…   Update your email preferences or unsubscribe here © 2026 Shortlysts.com. All Rights Reserved. 600 N Broad St Ste 5. Unit 2113 Middletown, DE 19709, United States Terms of Service